GLG LLC’s Global Cord Blood Corporation CO Stock Holding History

GLG LLC’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,100	Closed	-$61K	–	556
2016 Q1	$61K	Buy	+10,100	New	+$60.3K	﹤0.01%	535

Other funds holding CO

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

SCP

Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return

GLG LLC's CO Position: Q2 2016 in Review

GLG LLC sold out of Global Cord Blood Corporation (CO) in Q2 2016, closing a stake of 10,100 shares — an estimated $61K sold.

GLG LLC first reported a position in CO in Q1 2016 and held it in 1 quarter. The position peaked at $61K in Q1 2016. 29 funds tracked by Wall St. Rank hold CO as of Q2 2016.

GLG LLC reported no remaining Global Cord Blood Corporation position as of Q2 2016 after selling out during the quarter.
GLG LLC sold 10,100 Global Cord Blood Corporation shares in Q2 2016, an estimated $61K.
GLG LLC first reported a position in Global Cord Blood Corporation in Q1 2016 and held it in 1 quarter.
GLG LLC's Global Cord Blood Corporation position peaked at $61K in Q1 2016.
29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2016.

Based on GLG LLC's 13F filing for Q2 2016, filed 16 Aug 2016.